Last reviewed · How we verify

NCT04515940

Acceptability and Tolerance Study of a High Energy Peptide Based Paediatric Oral Nutritional Supplement for Children

Completed Last updated 22 October 2024
What this trial tests

trial testing acceptability, tolerance and palatability study in Nutrition Disorder, Child in 21 participants. Completed in 29 September 2020.

Timeline
30 October 2019
Primary endpoint
29 September 2020
29 September 2020

Quick facts

Lead sponsorSociété des Produits Nestlé (SPN)
StatusCompleted
Study typeOBSERVATIONAL
Enrollment21
Start date30 October 2019
Primary completion29 September 2020
Estimated completion29 September 2020
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Société des Produits Nestlé (SPN) — full company profile →

Who can join

Adults 1 to 10, any sex, with Nutrition Disorder, Child. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an acceptability study (including gastrointestinal tolerance, compliance and palatability) of a high energy peptide based paediatric oral nutritional supplement for children over 12 months of age. The acceptability data from a minimum of 15 participants will be collected in order to submit an application to the Advisory Committee on Borderline Substances (ACBS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Société des Produits Nestlé (SPN) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04515940.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing